Therefore, it is necessary to explore the regulatory mechanism between miRNAs and FGFR1 in FGFR1-amplified lung cancer, which may help explain the modest suppression of lung cancer by FGFR1 inhibitors, and, more importantly, develop novel and better therapies. This evidence concerns the gene FGFR1 and lung carcinoma.